AI Software to Detect Large Vessel Occlusion Cuts Workflow Time
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
THURSDAY, Sept. 21, 2023 -- Artificial intelligence (AI)-detected large vessel occlusion (LVO) ischemic stroke coupled with secure mobile phone application-based communication improves in-hospital acute ischemic stroke workflows, according to a study published online Sept. 18 in JAMA Neurology.
Juan Carlos Martinez-Gutierrez, M.D., from UT Health in Houston, and colleagues assessed whether automated computed tomography (CT) angiogram interpretation coupled with secure group messaging can improve in-hospital endovascular stroke therapy (EVT) workflows. The analysis included 243 participants with LVO stroke who presented through the emergency department and were treated with EVT at four comprehensive stroke centers.
The researchers found that implementation of the AI algorithm was associated with a reduction in door-to-groin time by 11.2 minutes, while time from CT scan initiation to EVT start declined by 9.8 minutes. However, there were no differences seen in intravenous tissue plasminogen activator treatment times or hospital length of stay. When adjusting for age, National Institutes of Health Stroke scale score, and the Alberta Stroke Program Early CT Score, there was no difference observed in the likelihood of functional independence as measured by the modified Rankin Scale score (odds ratio, 1.3; 95 percent confidence interval, 0.42 to 4.0).
"In a cohort as heterogeneous as this one, in which nearly all patients with EVT presenting through the emergency department were included, it is unlikely that our sample size would provide sufficient power to detect a difference in clinical outcomes with an 11-minute acceleration in care," the authors write.
One author disclosed ties to the medical technology industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
High Level of Approval Observed for Polygenic Embryo Screening
FRIDAY, May 17, 2024 -- There is a high level of approval for use of polygenic embryo screening, according to a study published online May 14 in JAMA Network Open. Rémy A...
AI Chatbots Can Generate Quality, Empathetic, Readable Responses
FRIDAY, May 17, 2024 -- For patient questions about cancer, artificial intelligence (AI) chatbots can generate quality, empathetic, and readable responses, according to a study...
Slight Decline Seen in U.S. Drug Overdose Deaths
THURSDAY, May 16, 2024 -- New 2023 provisional data from the National Center for Health Statistics show the first decline in deaths from drug overdose in the United States since...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.